Boostrix Pregnancy Registry: a Prospective, Exploratory, Cohort Study to Detect and Describe Any Abnormal Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Boostrix During Pregnancy or Within 28 Days Preceding Conception
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 16 Sep 2019 Status changed from recruiting to completed.
- 19 Mar 2018 Status changed from active, no longer recruiting to recruiting.
- 01 Mar 2018 Planned End Date changed from 31 Mar 2019 to 2 Aug 2019.